Organ Transplant Immunosuppressant Drugs

Organ Transplant Immunosuppressant Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • Rep Id : TMRGL1967
  • Published On : Sep 2015
  • No. of Pages : 102
  • Category : Pharmaceutical

 

1. Preface
   1.1. Report Description
   1.2. Market Segmentation
   1.3. Research Methodology

2. Executive Summary
   2.1. Organ Transplant Immunosuppressant Drugs: Market Snapshot
   2.2. Global Organ Transplant Immunosuppressant Drugs Market Share, by Geography, 2014 & 2023 (Value %)
   2.3. Global Organ Transplant Immunosuppressant Drugs Market, by Drug Class, 2014 (US$ Mn)
   2.4. Global Organ Transplant Immunosuppressant Drugs Market, by Transplant, 2014 (US$ Mn)

3. Organ Transplant Immunosuppressant Drugs Market - Industry Analysis
   3.1. Introduction
   3.2. Coverage: Immunosuppressant Drugs (U.S.)
   3.3. Market Dynamics
       3.3.1. Drivers
                3.3.1.1. Increasing incidences of chronic diseases leading to organ failure and disabilities
       3.3.2. Restraints
                3.3.2.1. High cost of procedure and inadequate insurance coverage
                3.3.2.2. Lack of donor organs
                3.3.2.3. Advent of stem cells
       3.3.3. Opportunities
                3.3.3.1. Newer medication options
   3.4. Market Attractiveness Analysis - Organ Transplant Immunosuppressant Drugs Market, by Geography, 2014
   3.5. Competitive Landscape 
       3.5.1. Global Organ Transplant Immunosuppressant Drugs Market Share, by Key Players, 2014 (%)

4. Market Segmentation – By Drug Class
   4.1. Introduction
   4.2. Global Organ Transplant Immunosuppressant Drugs Market Revenue, by Drug, 2013–2023 (US$ Mn)
   4.3. Global Calcineurin Inhibitors Market Revenue, 2013–2023 (US$ Mn)
   4.4. Global Antiproliferative Agents Market Revenue, 2013–2023 (US$ Mn)
   4.5. Global mTOR Inhibitors Market Revenue, 2013–2023 (US$ Mn)
   4.6. Global Antibodies Market Revenue, 2013–2023 (US$ Mn)
   4.7. Global Steroids Market Revenue, 2013–2023 (US$ Mn)

5. Market Segmentation – By Transplant
   5.1. Introduction
   5.2. Global Organ Transplant Immunosuppressant Drugs Market Revenue, by Transplant, 2013–2023 (US$ Mn)
   5.3. Global Kidney Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)
   5.4. Global Bone Marrow Transplant Immunosuppressant Drugs Market Revenue 2013-2023 (US$ Mn)
   5.5. Global Liver Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)
   5.6. Global Heart Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)
   5.7. Global Lung Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)
   5.8. Global Other Transplants Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)

6. Market Segmentation – By Geography
   6.1. Introduction
   6.2. Global Organ Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)
   6.3. North America Organ Transplant Immunosuppressant Drugs Market Revenue, by Country, 2013–2023 (US$ Mn)
   6.4. Europe Organ Transplant Immunosuppressant Drugs Market – Revenue, by Country, 2013–2023 (US$ Mn)
   6.5. Asia Pacific Organ Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)
   6.6. Latin America Organ Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)
   6.7. Rest of the World Organ Transplant Immunosuppressant Drugs Market Revenue, 2013–2023 (US$ Mn)

7. Company Profiles
   7.1. AbbVie, Inc.
   7.2. Allergan plc
   7.3. Astellas Pharma, Inc.
   7.4. Bristol-Myers Squibb Company
   7.5. F. Hoffmann-La Roche Ltd.
   7.6. GlaxoSmithKline plc
   7.7. Novartis AG
   7.8. Pfizer, Inc.
   7.9. Sanofi S.A.
   7.10. Veloxis Pharmaceuticals A/S

.